microdose of glp 1 GLP-1 microdosing is popular, but there's little evidence it works Microdosing GLP-1 Drugs: What To
Description
Despite numerous such groundbreaking discoveries, including identifying the intestine as a source of incretins [56], this practice did not necessarily identify hormones capable of sufficiently lowering body weight
Wegovy activates GLP-1 receptors to reduce appetite and slow digestion Adderall increases dopamine and norepinephrine to improve focus and attention Both medications can independently raise heart rate and blood pressure Neither medication directly interferes with the other's absorption or metabolism The concern lies primarily in overlapping physiological effects rather than direct drug interactions Cardiovascular Concerns When Combining These Medications The most significant concern when taking Wegovy and Adderall together relates to cardiovascular health

It has a high affinity to GLP-1R, strongly activating the GLP-1R Gs cAMP pathway without inducing measurable -arrestin recruitment signaling, which indicates it is a fully biased agonist

Patients (n = 9,340) were randomised to liraglutide or placebo for 3.5 and up to five years and showed durable effects on glycated haemoglobin and on body weight

doi: 10.1007/s43440-023-00496-y
